ZA929566B - Use of xanthine derivatives for stabilizing autoregulation of cerebral circulation. - Google Patents
Use of xanthine derivatives for stabilizing autoregulation of cerebral circulation.Info
- Publication number
- ZA929566B ZA929566B ZA929566A ZA929566A ZA929566B ZA 929566 B ZA929566 B ZA 929566B ZA 929566 A ZA929566 A ZA 929566A ZA 929566 A ZA929566 A ZA 929566A ZA 929566 B ZA929566 B ZA 929566B
- Authority
- ZA
- South Africa
- Prior art keywords
- autoregulation
- stabilizing
- xanthine derivatives
- cerebral circulation
- cerebral
- Prior art date
Links
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title 1
- 230000010455 autoregulation Effects 0.000 title 1
- 230000002490 cerebral effect Effects 0.000 title 1
- 229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 title 1
- 230000000087 stabilizing effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4140805 | 1991-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA929566B true ZA929566B (en) | 1993-06-16 |
Family
ID=6446782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA929566A ZA929566B (en) | 1991-12-11 | 1992-12-10 | Use of xanthine derivatives for stabilizing autoregulation of cerebral circulation. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0547508A1 (enExample) |
| JP (1) | JPH05246850A (enExample) |
| KR (1) | KR930012020A (enExample) |
| AU (1) | AU3000292A (enExample) |
| CA (1) | CA2085046A1 (enExample) |
| HU (2) | HUT62799A (enExample) |
| IL (1) | IL104037A0 (enExample) |
| MX (1) | MX9207156A (enExample) |
| TW (1) | TW209834B (enExample) |
| ZA (1) | ZA929566B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
| US5981536A (en) * | 1996-07-31 | 1999-11-09 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the modulation of apoptosis |
| WO2025046257A1 (en) * | 2023-08-25 | 2025-03-06 | Hikal Limited | A substantially pure propentofylline and preparation thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH062675B2 (ja) * | 1985-04-05 | 1994-01-12 | ヘキストジヤパン株式会社 | 記憶障害治療剤 |
| DE3525801A1 (de) * | 1985-07-19 | 1987-01-22 | Hoechst Ag | Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
| DE3942871A1 (de) * | 1989-12-23 | 1991-06-27 | Hoechst Ag | R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel |
-
1992
- 1992-07-25 TW TW081105887A patent/TW209834B/zh active
- 1992-12-09 IL IL104037A patent/IL104037A0/xx unknown
- 1992-12-10 MX MX9207156A patent/MX9207156A/es unknown
- 1992-12-10 JP JP4330129A patent/JPH05246850A/ja active Pending
- 1992-12-10 HU HU9203909A patent/HUT62799A/hu unknown
- 1992-12-10 ZA ZA929566A patent/ZA929566B/xx unknown
- 1992-12-10 KR KR1019920023765A patent/KR930012020A/ko not_active Withdrawn
- 1992-12-10 HU HU9203909A patent/HU9203909D0/hu unknown
- 1992-12-10 AU AU30002/92A patent/AU3000292A/en not_active Abandoned
- 1992-12-10 CA CA002085046A patent/CA2085046A1/en not_active Abandoned
- 1992-12-10 EP EP92121076A patent/EP0547508A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05246850A (ja) | 1993-09-24 |
| TW209834B (enExample) | 1993-07-21 |
| IL104037A0 (en) | 1993-05-13 |
| CA2085046A1 (en) | 1993-06-12 |
| HUT62799A (en) | 1993-06-28 |
| KR930012020A (ko) | 1993-07-20 |
| HU9203909D0 (en) | 1993-03-29 |
| EP0547508A1 (de) | 1993-06-23 |
| AU3000292A (en) | 1993-06-17 |
| MX9207156A (es) | 1993-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA917610B (en) | Xanthine derivatives | |
| JPS6448864A (en) | Continuous finish treatment for aqueous crude dye suspension | |
| IL87247A0 (en) | Pyrimidine derivatives | |
| IL104200A0 (en) | Heterocyclic derivatives | |
| GB9225283D0 (en) | Heterocyclic derivatives | |
| GB9124733D0 (en) | Derivatives of poly-4-amino-2-carboxy-1-methyl compounds | |
| GB9102804D0 (en) | Heterocyclic derivatives | |
| HU9501397D0 (en) | Xanthine derivatives for use as diuretics | |
| ZA883447B (en) | Pyrimidine derivatives | |
| SG48292G (en) | Ginkgolide derivatives | |
| AU3000292A (en) | Use of xanthine derivatives for stabilizing autoregulation of cerebral circulation | |
| IL120997A0 (en) | Use of theophylline derivatives for the treatment and prophylaxis of states of shock novel xanthine compounds and processes for their preparation | |
| OA09978A (en) | Heterocyclic compounds | |
| ZA914626B (en) | Cerebral function enhancing pyrimidinyl derivatives | |
| GB8726179D0 (en) | Heterocyclic derivatives | |
| EP0519370A3 (en) | Heterocyclic derivatives | |
| GB2209525B (en) | Pyrimidine derivatives | |
| GB9121205D0 (en) | Derivatives of poly-5-amino-3-carboxy-1-methyl compounds | |
| EP0460690A3 (en) | Use of phenolsulfophthaline derivatives for the treatment of osteoporosis | |
| ZA926417B (en) | New heterocyclic derivatives. | |
| HU9400358D0 (en) | Use of quinoziline derivatives as orexigenics | |
| GB9124345D0 (en) | Heterocyclic derivatives | |
| GB9124585D0 (en) | Heterocyclic derivatives | |
| GB9305655D0 (en) | Heterocyclic derivatives | |
| GB9107231D0 (en) | Heterocyclic derivatives |